Aims: To compare the clinical utility of contrast enhanced magnetic resonance imaging (MRI) to ultrasound (USS) and computed tomography (CT) in focal hepatic lesions (FHLs)
Methods: This retrospective study analysed 125 consecutive iron oxide enhanced (SPIO) MRI.
Results: MRI made a difference in 74% of patients who had USS and in 42% of patients who had a CT scan. In suspected cancer, MRI changed diagnosis in 58% and 37% (13/35), respectively.
Conclusions: MRI is superior to other noninvasive imaging modalities for lesion identification and characterisation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clinimag.2008.09.015 | DOI Listing |
Publication Analysis
Top Keywords
magnetic resonance
8
resonance imaging
8
focal hepatic
8
hepatic lesions
8
suspected cancer
8
clinical impact
4
impact magnetic
4
imaging diagnosing
4
diagnosing focal
4
lesions suspected
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!